• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
Generic NameImplant, dermal, for aesthetic use
ApplicantQ-Med AB
UPPSALA SE-75-752-
PMA NumberP030050
Supplement NumberS039
Date Received02/09/2022
Decision Date04/25/2023
Product Code LMH 
Docket Number 23M-1754
Notice Date 05/15/2023
Advisory Committee General & Plastic Surgery
Clinical TrialsNCT04124692
Supplement TypePanel Track
Supplement Reason Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
Approval for Sculptra. The device is indicated for correction of fine lines and wrinkles in the cheek region for use in immune-competent subjects.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
Labeling Part 2